Literature DB >> 31209619

Thermal ablation and systemic therapies in the metastatic liver: time for a "glocal" approach.

Andrea Veltri1, Marco Calandri2.   

Abstract

Year:  2019        PMID： 31209619     DOI： 10.1007/s00330-019-06290-w

Source DB:  PubMed          Journal:  Eur Radiol        ISSN： 0938-7994            Impact factor:   5.315


× No keyword cloud information.
  8 in total

Review 1.  Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy.

Authors:  Yasunori Minami; Naoshi Nishida; Masatoshi Kudo
Journal:  Eur Radiol       Date:  2019-04-08       Impact factor: 5.315

Review 2.  Fundamental Mechanisms of Immune Checkpoint Blockade Therapy.

Authors:  Spencer C Wei; Colm R Duffy; James P Allison
Journal:  Cancer Discov       Date:  2018-08-16       Impact factor: 39.397

Review 3.  Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.

Authors:  Joseph P Erinjeri; Gabriel C Fine; Gosse J Adema; Muneeb Ahmed; Julius Chapiro; Martijn den Brok; Rafael Duran; Stephen J Hunt; D Thor Johnson; Jens Ricke; Daniel Y Sze; Beau Bosko Toskich; Bradford J Wood; David Woodrum; S Nahum Goldberg
Journal:  Radiology       Date:  2019-04-23       Impact factor: 11.105

4.  Oncogenesis: An "Off-Target" Effect of Radiofrequency Ablation.

Authors:  Nir Rozenblum; Evelyne Zeira; Viviana Scaiewicz; Baruch Bulvik; Svetlana Gourevitch; Hagit Yotvat; Eithan Galun; S Nahum Goldberg
Journal:  Radiology       Date:  2015-08       Impact factor: 11.105

5.  Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.

Authors:  Waleed Shady; Elena N Petre; Mithat Gonen; Joseph P Erinjeri; Karen T Brown; Anne M Covey; William Alago; Jeremy C Durack; Majid Maybody; Lynn A Brody; Robert H Siegelbaum; Michael I D'Angelica; William R Jarnagin; Stephen B Solomon; Nancy E Kemeny; Constantinos T Sofocleous
Journal:  Radiology       Date:  2015-08-12       Impact factor: 11.105

6.  Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.

Authors:  Marco Calandri; Suguru Yamashita; Carlo Gazzera; Paolo Fonio; Andrea Veltri; Sara Bustreo; Rahul A Sheth; Steven M Yevich; Jean-Nicolas Vauthey; Bruno C Odisio
Journal:  Eur Radiol       Date:  2018-02-07       Impact factor: 5.315

7.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

Authors:  E Van Cutsem; A Cervantes; R Adam; A Sobrero; J H Van Krieken; D Aderka; E Aranda Aguilar; A Bardelli; A Benson; G Bodoky; F Ciardiello; A D'Hoore; E Diaz-Rubio; J-Y Douillard; M Ducreux; A Falcone; A Grothey; T Gruenberger; K Haustermans; V Heinemann; P Hoff; C-H Köhne; R Labianca; P Laurent-Puig; B Ma; T Maughan; K Muro; N Normanno; P Österlund; W J G Oyen; D Papamichael; G Pentheroudakis; P Pfeiffer; T J Price; C Punt; J Ricke; A Roth; R Salazar; W Scheithauer; H J Schmoll; J Tabernero; J Taïeb; S Tejpar; H Wasan; T Yoshino; A Zaanan; D Arnold
Journal:  Ann Oncol       Date:  2016-07-05       Impact factor: 32.976

8.  Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial.

Authors:  Theo Ruers; Frits Van Coevorden; Cornelis J A Punt; Jean-Pierre E N Pierie; Inne Borel-Rinkes; Jonathan A Ledermann; Graeme Poston; Wolf Bechstein; Marie-Ange Lentz; Murielle Mauer; Gunnar Folprecht; Eric Van Cutsem; Michel Ducreux; Bernard Nordlinger
Journal:  J Natl Cancer Inst       Date:  2017-09-01       Impact factor: 11.816
  8 in total
  1 in total

Review 1.  Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know.

Authors:  Marco Calandri; Giulia Siravegna; Andrea Veltri; Bruno C Odisio; Steven M Yevich; Giuseppe Stranieri; Carlo Gazzera; Scott Kopetz; Paolo Fonio; Sanjay Gupta; Alberto Bardelli
Journal:  Eur Radiol       Date:  2020-03-19       Impact factor: 5.315
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.